MPRS Stock Overview
MediPress Health-Limited Partnership, is a research and development life science partnership and venture capital firm specializing in seed/startups investments.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
MediPress Health-Limited Partnership Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₪0.85 |
| 52 Week High | ₪1.60 |
| 52 Week Low | ₪0.43 |
| Beta | 0 |
| 1 Month Change | -3.40% |
| 3 Month Change | -13.15% |
| 1 Year Change | 24.02% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -56.13% |
Recent News & Updates
Recent updates
Shareholder Returns
| MPRS | IL Capital Markets | IL Market | |
|---|---|---|---|
| 7D | -1.7% | 0.8% | 2.9% |
| 1Y | 24.0% | 15.2% | 10.8% |
Return vs Industry: MPRS exceeded the IL Capital Markets industry which returned 15.2% over the past year.
Return vs Market: MPRS exceeded the IL Market which returned 10.8% over the past year.
Price Volatility
| MPRS volatility | |
|---|---|
| MPRS Average Weekly Movement | n/a |
| Capital Markets Industry Average Movement | 3.6% |
| Market Average Movement | 4.4% |
| 10% most volatile stocks in IL Market | 8.3% |
| 10% least volatile stocks in IL Market | 3.1% |
Stable Share Price: MPRS has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine MPRS's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2021 | n/a | Joseph Press | n/a |
MediPress Health-Limited Partnership, is a research and development life science partnership and venture capital firm specializing in seed/startups investments. The firm seeks to invest in medical research and development companies. Its portfolio companies engage in the treatment of cancer with proton radiation therapy; and the development of non-surgical vaginal solutions for women with various pelvic floor disorders.
MediPress Health-Limited Partnership Fundamentals Summary
| MPRS fundamental statistics | |
|---|---|
| Market cap | ₪12.79m |
| Earnings (TTM) | ₪0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs MPRS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MPRS income statement (TTM) | |
|---|---|
| Revenue | ₪0 |
| Cost of Revenue | ₪0 |
| Gross Profit | ₪0 |
| Other Expenses | ₪0 |
| Earnings | ₪0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did MPRS perform over the long term?
See historical performance and comparison